000			02315 a2200613 4500
005			20250515002641.0
264		0	_c20060501
008			200605s 0 0 eng d
022			_a1044-7431
024	7		_a10.1016/j.mcn.2005.08.016 _2doi
040			_aNLM _beng _cNLM
100	1		_aGarry, E M
245	0	0	_aActivation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia. _h[electronic resource]
260			_bMolecular and cellular neurosciences _cDec 2005
300			_a523-37 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aDisease Models, Animal
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aInflammation Mediators _xpharmacology
650	0	4	_aMAP Kinase Signaling System _xdrug effects
650	0	4	_aMale
650	0	4	_aMitogen-Activated Protein Kinase 1 _xdrug effects
650	0	4	_aNeuralgia _xmetabolism
650	0	4	_aNeuroglia _xdrug effects
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aPeripheral Nerve Injuries
650	0	4	_aPeripheral Nerves _xmetabolism
650	0	4	_aPeripheral Nervous System Diseases _xmetabolism
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPhysical Stimulation
650	0	4	_aPosterior Horn Cells _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReceptors, N-Methyl-D-Aspartate _xdrug effects
650	0	4	_aReceptors, Neurokinin-2 _xdrug effects
650	0	4	_aReceptors, Vasoactive Intestinal Peptide, Type II _xdrug effects
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
650	0	4	_aXanthines _xpharmacology
650	0	4	_ap38 Mitogen-Activated Protein Kinases _xdrug effects
700	1		_aDelaney, A
700	1		_aBlackburn-Munro, G
700	1		_aDickinson, T
700	1		_aMoss, A
700	1		_aNakalembe, I
700	1		_aRobertson, D C
700	1		_aRosie, R
700	1		_aRobberecht, P
700	1		_aMitchell, R
700	1		_aFleetwood-Walker, S M
773	0		_tMolecular and cellular neurosciences _gvol. 30 _gno. 4 _gp. 523-37
856	4	0	_uhttps://doi.org/10.1016/j.mcn.2005.08.016 _zAvailable from publisher's website
999			_c15832700 _d15832700